568 related articles for article (PubMed ID: 27764902)
1. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
2. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
3. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
4. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
5. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
6. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of initial therapy for idiopathic membranous nephropathy.
Sato M; Takei T; Moriyama T; Itabashi M; Nitta K
Clin Exp Nephrol; 2017 Oct; 21(5):842-851. PubMed ID: 27999961
[TBL] [Abstract][Full Text] [Related]
8. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
[TBL] [Abstract][Full Text] [Related]
9. Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-D-glucosaminidase in glomerulonephritis.
Bazzi C; Rizza V; Olivieri G; Casellato D; D'Amico G
J Nephrol; 2015 Oct; 28(5):541-8. PubMed ID: 25227764
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Idiopathic Membranous Nephropathy: A Retrospective Study.
Rozenberg I; Kotliroff A; Zahavi T; Benchetrit S
Isr Med Assoc J; 2018 Mar; 20(3):186-189. PubMed ID: 29527859
[TBL] [Abstract][Full Text] [Related]
11. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness.
Bazzi C; Rizza V; Casellato D; Tofik R; Berg AL; Gallieni M; D'Amico G; Bakoush O
BMC Nephrol; 2014 May; 15():74. PubMed ID: 24886340
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
13. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.
van den Brand JA; Hofstra JM; Wetzels JF
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1242-8. PubMed ID: 22595828
[TBL] [Abstract][Full Text] [Related]
15. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
17. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
[TBL] [Abstract][Full Text] [Related]
20. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.
Chen Y; Tang L; Feng Z; Cao X; Sun X; Liu M; Liu S; Zhang X; Li P; Wei R; Qiu Q; Cai G; Chen X
J Nephrol; 2014 Jun; 27(3):307-16. PubMed ID: 24523071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
